0,985  0,001  Antiparkinsonian, tremor relieving
0,974  0,002  Spasmolytic
0,837  0,007  Embryotoxic
0,829  0,007  Teratogen
0,821  0,004  Psychostimulant
0,813  0,003  Sulfotransferase substrate
0,800  0,003  Cholinergic antagonist
0,801  0,005  Respiratory analeptic
0,789  0,005  Antiasthmatic
0,780  0,003  Acetylcholine antagonist
0,777  0,003  Anesthetic
0,772  0,005  Toll-Like receptor 7 agonist
0,768  0,005  Toll-Like receptor agonist
0,755  0,005  Antiparkinsonian
0,746  0,002  Dopamine D5 antagonist
0,734  0,006  Analeptic
0,723  0,002  Acetylcholine muscarinic antagonist
0,716  0,003  Acetylcholine M1 receptor antagonist
0,716  0,004  Sedative
0,714  0,005  Skin irritative effect
0,682  0,005  Chronic obstructive pulmonary disease treatment
0,663  0,004  Irritable Bowel syndrome treatment
0,663  0,008  Eye irritation, high
0,666  0,013  Carcinogenic
0,627  0,018  CYP2C9 substrate
0,606  0,003  Antiemetic
0,603  0,004  Bronchodilator
0,597  0,003  Acetylcholine nicotinic antagonist
0,629  0,046  Antiinflammatory
0,578  0,005  Antiulcerative
0,574  0,031  CYP3A4 substrate
0,549  0,037  Analgesic
0,521  0,013  Cardiotonic
0,523  0,019  Ulceration
0,493  0,009  P-glycoprotein inhibitor
0,503  0,020  Antiischemic
0,516  0,042  Transcription factor NF kappa B inhibitor
0,494  0,021  Mutagenic
0,464  0,003  Acetylcholine M2 receptor antagonist
0,460  0,003  Acetylcholine M3 receptor antagonist
0,455  0,003  Acetylcholine M4 receptor antagonist
0,450  0,002  Antihypermotility
0,476  0,040  Antipruritic, allergic
0,435  0,003  Movement disorders treatment
0,450  0,027  NOS3 expression inhibitor
0,432  0,013  Antiarrhythmic
0,431  0,019  Dependence treatment
0,427  0,029  Sensitization
0,401  0,006  Acute respiratory distress syndrome (ARDS) treatment
0,407  0,015  Sodium/bile acid cotransporter inhibitor
0,429  0,044  Cholesterol antagonist
0,394  0,026  Antihypoxic
0,386  0,023  Anticonvulsant
0,397  0,036  CYP2D6 inhibitor
0,364  0,012  Pneumotoxic
0,347  0,010  Antidiarrheal
0,369  0,044  CTGF expression inhibitor
0,357  0,035  Cardiodepressant
0,344  0,027  5 Hydroxytryptamine uptake stimulant
0,393  0,080  TNF expression inhibitor
0,314  0,005  Antinephritic
0,399  0,092  Cyclophilin D inhibitor
0,399  0,092  Antidiabetic
0,318  0,028  Platelet adhesion inhibitor
0,361  0,081  Immunosuppressant
0,283  0,004  Acetylcholine M5 receptor antagonist
0,293  0,016  Interleukin 6 antagonist
0,357  0,084  GST A substrate
0,289  0,017  Antidote
0,314  0,044  Vasodilator
0,270  0,001  Antidote, organophosphates
0,326  0,060  Lipoprotein disorders treatment
0,331  0,066  CYP2D6 substrate
0,297  0,034  Anesthetic general
0,284  0,021  Lipid peroxidase inhibitor
0,276  0,014  UGT2B9 substrate
0,303  0,050  Antineoplastic (liver cancer)
0,257  0,004  Chronic obstructive bronchitis treatment
0,252  0,006  Neuronal nicotinic receptor antagonist
0,319  0,077  Antithrombotic
0,294  0,054  Platelet antagonist
0,278  0,040  Abortion inducer
0,311  0,077  Hepatic disorders treatment
0,334  0,101  CYP2C19 inhibitor
0,249  0,019  Cocaine dependence treatment
0,291  0,066  UGT2B4 substrate
0,247  0,023  Alpha-N-acetylglucosaminidase inhibitor
0,279  0,056  Hypolipemic
0,274  0,060  Angiogenesis stimulant
0,254  0,040  UGT2B7 substrate
0,220  0,013  Cyclooxygenase 3 inhibitor
0,234  0,027  Allergic rhinitis treatment
0,246  0,040  Diabetic retinopathy treatment
0,247  0,043  Antimigraine
0,200  0,005  Antiemphysemic
0,221  0,031  Aldehyde oxidase substrate
0,262  0,076  Radiosensitizer
0,211  0,027  Antirickettsial
0,230  0,047  UGT1A4 substrate
0,273  0,091  Antidepressant
0,256  0,074  Antipyretic
0,275  0,093  Interleukin 2 agonist
0,275  0,093  Antifungal
0,256  0,076  Antihypercholesterolemic
0,240  0,065  Cytotoxic
0,179  0,005  Dopamine transporter inhibitor
0,179  0,007  Ca2+-transporting ATPase inhibitor
0,209  0,039  Protein kinase stimulant
0,277  0,108  Vasodilator, coronary
0,275  0,106  ICAM1 expression inhibitor
0,273  0,106  Antiallergic
0,183  0,018  Mucolytic
0,214  0,052  Antipruritic, non-allergic
0,185  0,024  Expectorant
0,227  0,067  Antihypertriglyceridemic
0,207  0,047  VEGF expression inhibitor
0,212  0,054  Antianginal
0,160  0,004  Acetylcholine M5 receptor agonist
0,174  0,020  Antineoplastic, alkylator
0,323  0,169  Caspase 9 stimulant
0,205  0,053  Lipocortins synthesis antagonist
0,236  0,086  Proliferative diseases treatment
0,232  0,086  Antidiabetic symptomatic
0,261  0,117  FMO1 substrate
0,188  0,045  Arachidonic acid antagonist
0,241  0,098  CYP2C19 substrate
0,189  0,047  ATPase inhibitor
0,195  0,054  UGT1A3 substrate
0,192  0,054  Antihelmintic (Nematodes)
0,216  0,080  Peptidyltransferase inhibitor
0,250  0,114  Mood disorders treatment
0,212  0,079  Antiparasitic
0,200  0,070  UDP-glucuronosyltransferase substrate
0,226  0,098  Antioxidant
0,230  0,105  Immunostimulant
0,160  0,034  Growth stimulant
0,198  0,073  Non-steroidal antiinflammatory agent
0,278  0,152  Antibacterial
0,146  0,023  Toll-Like receptor 4 antagonist
0,191  0,067  Myocardial ischemia treatment
0,182  0,059  Toxic, respiratory center
0,225  0,106  Antineoplastic (ovarian cancer)
0,225  0,107  Chemoprotective
0,138  0,022  Antibiotic
0,142  0,026  Prolactin inhibitor
0,160  0,044  Anesthetic local
0,186  0,073  Nitric oxide antagonist
0,235  0,122  GST M1-1 substrate
0,172  0,061  Cytidine deaminase inhibitor
0,173  0,064  UGT2B10 substrate
0,138  0,030  Acetylcholine agonist
0,188  0,080  UGT1A1 substrate
0,182  0,078  Antihelmintic
0,122  0,018  ATPase (Vacuolar H+) inhibitor
0,286  0,182  Apoptosis agonist
0,117  0,013  Glycine receptor agonist
0,194  0,092  Antiparkinsonian, rigidity relieving
0,209  0,110  DNA synthesis inhibitor
0,198  0,101  Cytostatic
0,134  0,037  UGT2B1 substrate
0,136  0,046  Microtubule formation inhibitor
0,110  0,022  Dopamine D1 antagonist
0,119  0,033  Tourette's syndrome treatment
0,122  0,037  Antineoplastic alkaloid
0,137  0,052  Cholesterol synthesis inhibitor
0,156  0,071  Interferon gamma antagonist
0,118  0,035  Acetylcholine M3 receptor agonist
0,156  0,078  Uterine stimulant
0,089  0,010  Nicotinic receptor alpha4 subunit antagonist
0,202  0,125  UGT1A9 substrate
0,095  0,018  Acetylcholine muscarinic agonist
0,208  0,132  Anxiolytic
0,104  0,028  Nicotinic alpha4beta2 receptor antagonist
0,131  0,059  Alkylator
0,092  0,022  Anticholelithogenic
0,181  0,112  UGT1A6 substrate
0,125  0,057  Alcohol dehydrogenase substrate
0,201  0,133  Tyrosine 3 hydroxylase inhibitor
0,091  0,023  Antitreponemal
0,085  0,019  Antiviral (Parainfluenza)
0,108  0,043  Antineoplastic antibiotic
0,094  0,030  Narcotic antagonist
0,095  0,032  Estrogen-related receptor beta agonist
0,096  0,033  Analgesic, opioid
0,238  0,176  Atherosclerosis treatment
0,085  0,023  Dopamine uptake inhibitor
0,082  0,021  Antimycoplasmal
0,188  0,132  5 Hydroxytryptamine release stimulant
0,114  0,058  Acetylcholine release stimulant
0,082  0,026  Adrenaline uptake inhibitor
0,071  0,016  Alpha-mannosidase inhibitor
0,145  0,091  Carcinogenic, group 1
0,203  0,150  CYP1A2 substrate
0,200  0,149  Gastrin inhibitor
0,141  0,092  Aldose reductase substrate
0,112  0,070  Antitussive
0,208  0,167  Vasodilator, peripheral
0,114  0,073  Adenylate cyclase inhibitor
0,149  0,109  Phospholipase C inhibitor
0,061  0,023  Glucose-6-phosphate translocase inhibitor
0,087  0,050  Antiprotozoal activity enhancer
0,085  0,049  T cell inhibitor
0,126  0,089  UGT2B15 substrate
0,098  0,062  Sphingomyelinase inhibitor
0,055  0,020  Mannosidase inhibitor
0,128  0,094  Skeletal muscle relaxant
0,091  0,058  Triose-phosphate isomerase inhibitor
0,160  0,127  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,129  0,097  Cholinergic
0,096  0,065  UDP-glucose 4-epimerase inhibitor
0,147  0,116  LDLR expression enhancer
0,045  0,017  Vesicle monoamine transporter inhibitor
0,033  0,006  Vesicular acetylcholine transporter inhibitor
0,101  0,074  GST T1-1 substrate
0,184  0,158  Flavin-containing monooxygenase substrate
0,121  0,095  Acaricide
0,057  0,032  Nicotinic receptor alpha7 subunit antagonist
0,044  0,019  Cholesterol absorption inhibitor
0,096  0,072  Antiviral (Poxvirus)
0,131  0,108  Muscle relaxant
0,215  0,192  Calcium channel activator
0,111  0,089  Cyclooxygenase 1 inhibitor
0,062  0,041  Beta 2 adrenoreceptor agonist
0,097  0,077  Excitatory amino acid transporter EAAC1 inhibitor
0,098  0,078  Rhinitis treatment
0,038  0,019  Squalene synthetase inhibitor
0,041  0,023  5-Alpha-reductase inhibitor
0,128  0,110  Growth hormone agonist
0,091  0,074  UGT2B11 substrate
0,067  0,050  Phosphofructokinase-1 inhibitor
0,161  0,144  Tumour necrosis factor alpha release inhibitor
0,097  0,081  Cystathionine beta-synthase inhibitor
0,215  0,198  Antineoplastic (endocrine cancer)
0,095  0,080  Choleretic
0,059  0,043  Androgen agonist
0,152  0,137  Aldehyde oxidase inhibitor
0,051  0,036  5 Hydroxytryptamine 4 antagonist
0,057  0,043  Lipocortins synthesis agonist
0,046  0,034  Microtubule stabilization
0,207  0,195  Cognition disorders treatment
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,136  0,126  Hepatoprotectant
0,118  0,110  SULT1A3 substrate
0,162  0,154  DNA damaging
0,183  0,176  AR expression inhibitor
0,074  0,068  Glycine receptor antagonist
0,119  0,113  Antiviral (Herpes)
0,028  0,022  1,3-Beta-glucan synthase inhibitor
0,067  0,063  Na+ K+ transporting ATPase inhibitor
0,044  0,040  Glucose-6-phosphate isomerase inhibitor
0,139  0,135  Succinate dehydrogenase inhibitor
0,032  0,028  Tubulin agonist
0,161  0,157  Interleukin agonist
0,070  0,069  Histamine H1 receptor antagonist

